文献速递眼底病与葡萄膜炎

补充抗氧化剂对非晚期年龄相关性黄斑变性视功能的影响:一项头对头随机临床试验

The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2017-01-01

121例非晚期年龄相关性黄斑变性患者随机分为两组,分别接受含或不含10 mg内消旋玉米黄质的抗氧化补充剂。随时间推移,主要终点6 cpd字母对比敏感度显著改善(P=0.013),两组间统计学相当(P=0.881);多项次要视功能指标及黄斑色素也显著改善,组间统计学相当。

要点

  • 补充抗氧化剂后6 cpd字母对比敏感度随时间显著改善(P=0.013),两组间统计学相当(P=0.881)。
  • 多项次要视功能指标随时间显著改善(P<0.05),两组间统计学相当(P>0.05)。
  • 黄斑色素在各偏心度随时间显著增加(P<0.0005),两组增幅统计学相当(P>0.05)。

核心结论

  • 非晚期年龄相关性黄斑变性患者补充抗氧化剂可显著增加黄斑色素并改善对比敏感度及其他视功能指标。

研究设计与样本

  • 头对头随机临床试验,121例非晚期年龄相关性黄斑变性患者随机分为两组。
  • 第1组60例接受年龄相关眼病研究2配方加低剂量25 mg锌并添加10 mg内消旋玉米黄质。
  • 第2组61例接受年龄相关眼病研究2配方加低剂量25 mg锌。
  • 视功能评估包括最佳矫正视力、对比敏感度、眩光失能、视网膜杂散光、光应激恢复时间、阅读性能和美国国家眼科研究所视功能问卷-25。
  • 黄斑色素采用定制异色闪烁光度法测量。

主要发现

  • 主要终点6 cpd字母对比敏感度随时间显著改善(P=0.013),两组间统计学相当(P=0.881)。
  • 1.2和2.4 cpd字母对比敏感度、所有空间频率的明视和暗视对比敏感度随时间显著改善(P<0.05),两组间统计学相当(P>0.05)。
  • 1.5、3和6 cpd暗视眩光失能及1.5、3、6和12 cpd明视眩光失能随时间显著改善(P<0.05),两组间统计学相当(P>0.05)。
  • 光应激恢复时间、视网膜杂散光、平均和最大阅读速度随时间显著改善(P<0.05),两组间统计学相当(P>0.05)。
  • 各偏心度黄斑色素随时间显著增加(P<0.0005),两组增幅统计学相当(P>0.05)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate the impact of supplemental macular carotenoids (including versus not including meso-zeaxanthin) in combination with coantioxidants on visual function in patients with nonadvanced age-related macular degeneration. METHODS: In this study, 121 participants were randomly assigned to group 1 (Age-Related Eye Disease Study 2 formulation with a low dose [25 mg] of zinc and an addition of 10 mg meso-zeaxanthin; n = 60) or group 2 (Age-Related Eye Disease Study 2 formulation with a low dose [25 mg] of zinc; n = 61). Visual function was assessed using best-corrected visual acuity, contrast sensitivity (CS), glare disability, retinal straylight, photostress recovery time, reading performance, and the National Eye Institute Visual Function Questionnaire-25. Macular pigment was measured using customized heterochromatic flicker photometry. RESULTS: There was a statistically significant improvement in the primary outcome measure (letter CS at 6 cycles per degree [6 cpd]) over time (P = 0.013), and this observed improvement was statistically comparable between interventions (P = 0.881). Statistically significant improvements in several secondary outcome visual function measures (letter CS at 1.2 and 2.4 cpd; mesopic and photopic CS at all spatial frequencies; mesopic glare disability at 1.5, 3, and 6 cpd; photopic glare disability at 1.5, 3, 6, and 12 cpd; photostress recovery time; retinal straylight; mean and maximum reading speed) were also observed over time (P < 0.05, for all), and were statistically comparable between interventions (P > 0.05, for all). Statistically significant increases in macular pigment at all eccentricities were observed over time (P < 0.0005, for all), and the degree of augmentation was statistically comparable between interventions (P > 0.05). CONCLUSIONS: Antioxidant supplementation in patients with nonadvanced age-related macular degeneration results in significant increases in macular pigment and improvements in CS and other measures of visual function. (Clinical trial, http://www.isrctn.com/ISRCTN13894787).

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Akuffo KO, Beatty S, Peto T, et al. The Impact of Supplemental Antioxidants on Visual Function in Nonadvanced Age-Related Macular Degeneration: A Head-to-Head Randomized Clinical Trial. Invest Ophthalmol Vis Sci. 2017. PMID: 29053808. doi:10.1167/iovs.16-21192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。